Stryker (SYK) Cash from Financing Activities (2009 - 2026)

Stryker's (SYK) quarterly Cash from Financing Activities came in at -$1.5 billion in Q1 2026, down 159.59% year-on-year from $2.5 billion in Q1 2025, and down 38.15% on a QoQ basis from -$1.1 billion in Q4 2025.

Stryker (SYK) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Stryker (SYK) has 18 years of Cash from Financing Activities data on file, last reported at -$1.5 billion in Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 159.59% year-over-year to -$1.5 billion in Q1 2026; TTM through Mar 2026 was -$3.9 billion, a 261.97% decrease from a year earlier, with the FY2025 full-year figure at $113.0 million, up 121.52% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at -$1.5 billion, down from -$1.1 billion in the prior quarter.
  • Over the last five years, Cash from Financing Activities for SYK reached as high as $2.7 billion in Q3 2024 and fell as low as -$1.8 billion in Q4 2024.
  • Historically, Cash from Financing Activities has averaged -$250.9 million across 5 years, with a median of -$446.0 million in 2022.
  • On a YoY basis, Cash from Financing Activities climbed as much as 728.67% in 2024 and fell as far as 527.27% in 2024.
  • Year by year, Cash from Financing Activities stood at -$446.0 million in 2022, then soared by 35.87% to -$286.0 million in 2023, then slumped by 527.27% to -$1.8 billion in 2024, then soared by 39.07% to -$1.1 billion in 2025, then plunged by 38.15% to -$1.5 billion in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were -$1.5 billion in Q1 2026, -$1.1 billion in Q4 2025, and -$339.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn -97.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.51 Bn
Mar 31, 2026 -1.51 Bn
Dec 31, 2025 -1.09 Bn
Dec 31, 2025 -1.09 Bn
Sep 30, 2025 -339.00 Mn
Sep 30, 2025 -339.00 Mn
Jun 30, 2025 -989.00 Mn
Jun 30, 2025 -989.00 Mn
Mar 31, 2025 2.53 Bn
Mar 31, 2025 2.53 Bn
Dec 31, 2024 -1.79 Bn
Dec 31, 2024 -1.79 Bn
Sep 30, 2024 2.65 Bn
Sep 30, 2024 2.65 Bn
Jun 30, 2024 -966.00 Mn
Jun 30, 2024 -966.00 Mn
Mar 31, 2024 -418.00 Mn
Mar 31, 2024 -418.00 Mn
Dec 31, 2023 -286.00 Mn
Dec 31, 2023 -286.00 Mn